Reducing the number of manual steps involved in cell therapy production using automation would help the industry reduce staffing costs, improve consistency, and help more patients gain access to these potentially lifesaving medicines, say researchers. The post Reduce Staffing Costs and Boost Access with Cell Therapy Automation appeared first on GEN - Genetic Engineering and Biotechnology News.
